was successfully added to your cart.

Your SEO optimized title page contents

Governor Pat Quinn has the opportunity to make history with his signature approving the Illinois Compassionate Use of Medical Cannabis Pilot Program Act, but interestingly enough, even if he doesn't sign the bill, it will go into law.  The Illinois Constitution stipulates, "Any bill not so returned by the Governor within 60 calendar days after it is presented to him shall become law." In this case, the measure would be effective August 5th.  In anticipation of that event, Quantum 9 is providing consulting and lobbying services to write public policy, support applicants to obtain cultivation and dispensary licenses, as well as design and build those facilities.

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

One Comment

Leave a Reply